Clinical features of influenza disease in admitted children during the first postpandemic season and risk factors for hospitalization: A multicentre Spanish experience

Clinical Microbiology and Infection

Volumn 19, Issue 3, 2013, Pages

  Launes, C ^a   Garcia Garcia J J ^a   Martinez Planas A ^a   Moraga, F ^b   Soldevila, N ^c   Astigarraga, I ^d   Aristegui J ^e   Korta, J ^f   Quintana, J M ^c,g   Torner, N ^c,h   Dominguez A ^a,c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d HOSPITAL DE CRUCES   (Spain)

^e HOSPITAL DE BASURTO   (Spain)

^f HOSPITAL DONOSTIA   (Spain)

^g HOSPITAL DE GALDAKAO   (Spain)

^h AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

Author keywords

Case control; Influenza; Paediatrics; Postpandemic; Risk factors

Indexed keywords

ANTIVIRUS AGENT;

ADOLESCENT; ANTIVIRAL THERAPY; ARTICLE; CASE CONTROL STUDY; CHILD; CHRONIC LUNG DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFANT; INFLUENZA; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROLOGIC DISEASE; OUTPATIENT CARE; PANDEMIC; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SCHOOL CHILD; SPAIN; THORAX RADIOGRAPHY;

EID: 84874302212     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12106     Document Type: Article

References (30)

1. Centers for Disease Control and Prevention. 2009-2010 Influenza Season Summary. http://www.cdc.gov/flu/weekly/weeklyarchives2009-2010/09-10summary.htm (Accessed 15 February 2012).
2. Launes C, García-García JJ, Jordán I, Martínez-Planas A, Selva L, Muñoz-Almagro C. Influenza A H1N1 infections: delays in starting treatment with oseltamivir were associated with a more severe disease. Pediatr Infect Dis J 2011; 30: 622-625.
3. Song X, DeBiasi RL, Campos JM, Fagbuyi DB, Jacobs BR, Singh N. Comparison of pandemic and seasonal influenza A infections in pediatric patients: were they different? Influenza Other Resp Viruses 2012; 6: 25-27.
4. Rahamat-Langendoen JC, Tutuhatunewa ED, Schölvinck EH et al. Influenza in the immediate post-pandemic era: a comparison with seasonal and pandemic influenza in hospitalized patients. J Clin Virol 2012; 54: 135-140.
5. de Rosal T, Baquero-Artigao F, Calvo C et al. Pandemic H1N1 influenza-associated hospitalizations in children in Madrid, Spain. Influenza Other Resp Viruses 2011; 5: e544-e551.
6. Dawood FS, Kamimoto L, D'Mello TA et al. Children with asthma hospitalized with seasonal or pandemic influenza, 2003-2009. Pediatrics 2011; 128: e27-e32.
7. Morens DM, Taubenberger JK, Harvey HA, Memoli MJ. The 1918 influenza pandemic: lessons for 2009 and the future. Crit Care Med 2010; 38: e10-e20.
8. World Health Organization. WHO recommendations for the post-pandemic period, Pandemic (H1N1) 2009 briefing note 23. http://www.who.int/csr/disease/swineflu/notes/briefing_20100810/en/index.html (Accessed 15 February 2012).
9. Poulakou G, Souto J, Balcells J et al. First influenza season after the 2009 pandemic influenza: characteristics of intensive care unit admissions in adults and children in Vall d'Hebron Hospital. Clin Microbiol Infect 2012; 18: 374-380.
10. Louie JK, Schechter R, Honarmand S et al. Severe pediatric influenza in California, 2003-2005: implications for immunization recommendations. Pediatrics 2006; 117: e610-e618.
11. Coffin SE, Zaoutis TE, Rosenquist AB et al. Incidence, complications, and risk factors for prolonged stay in children hospitalized with community-acquired influenza. Pediatrics 2007; 119: 740-748.
12. Engelhard D, Bromberg M, Averbuch D et al. Increased extent of and risk factors for pandemic (H1N1) 2009 and seasonal influenza among children, Israel. Emerg Infect Dis 2011; 17: 1740-1743.
13. Ostovar GA, Rubin LG, Rajan S, Sood SK, Kohn N. Comparison of the clinical features of children hospitalized with pandemic 2009 A:H1N1 and seasonal influenza. Clin Pediatr (Phila) 2011; 50: 348-354.
14. Launes C, García-García JJ, Martínez-Planas A et al. 2009 H1N1: risk factors for hospitalization in a matched case-control study. Eur J Pediatr 2012; 171: 1127-1131.
15. van Gageldonk-Lafeber AB, Hooiveld M, Meijer A et al. The relative clinical impact of 2009 pandemic influenza A (H1N1) in the community compared to seasonal influenza in the Netherlands was most marked among 5-14 year olds. Influenza Other Resp Viruses 2011; 5: e513-e520.
16. Poehling KA, Fairbrother G, Zhu Y et al. Practice and child characteristics associated with influenza vaccine uptake in young children. Pediatrics 2010; 126: 665-673.
17. Dubé E, Fannie D, Vladimir G et al. A(H1N1) pandemic influenza and its prevention by vaccination: paediatricians' opinions before and after the beginning of the vaccination campaign. BMC Public Health 2011; 11: 128.
18. Nichol KL. Cost-effectiveness and socio-economic aspects of childhood influenza vaccination. Vaccine 2011; 29: 7554-7558.
19. Bender JM, Ampofo K, Gesteland P et al. Development and validation of a risk score for predicting hospitalization in children with influenza virus infection. Pediatr Emerg Care 2009; 25: 369-375.
20. Garg S, Chaves SS, Pérez A et al. Reduced influenza antiviral treatment among children and adults hospitalized with laboratory-confirmed influenza infection in the year following the 2009 pandemic. Clin Infect Dis 2012; 55: e18-e21.
21. Rodríguez A, Díaz E, Martín-Loeches I et al. Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A. J Antimicrob Chemother 2011; 66: 1140-1149.
22. Coffin SE, Leckerman K, Keren R, Hall M, Localio R, Zaoutis TE. Oseltamivir shortens hospital stays of critically ill children hospitalized with seasonal influenza: a retrospective cohort study. Pediatr Infect Dis J 2011; 30: 962-966.
23. Wang K, Shun-Shin M, Gill P, Perera R, Harnden A. Neuraminidase inhibitors for preventing and treating influenza in children (published trials only). Cochrane Database Syst Rev 2012; 4: CD002744.
24. Carr S, Ilyushina NA, Franks J et al. Oseltamivir-resistant influenza A and B viruses pre- and postantiviral therapy in children and young adults with cancer. Pediatr Infect Dis J 2011; 30: 284-288.
25. Garg S, Finelli L, Fry A. Antiviral treatment for children with influenza: what's the evidence? Pediatr Infect Dis J 2012; 31: 662.
26. Martin-Loeches I, Lisboa T, Rhodes A et al. Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection. Intensive Care Med 2011; 37: 272-283.
27. Viasus D, Paño-Pardo JR, Cordero E et al. Effect of immunomodulatory therapies in patients with pandemic influenza A (H1N1) 2009 complicated by pneumonia. J Infect 2011; 62: 193-199.
28. Almansa R, Anton A, Ramirez P et al. Direct association between pharyngeal viral secretion and host cytokine response in severe pandemic influenza. BMC Infect Dis 2011; 11: 232.
29. Kawashima H, Go S, Kashiwagi Y et al. Cytokine profiles of suction pulmonary secretions from children infected with pandemic influenza A(H1N1) 2009. Crit Care 2010; 14: 411.
30. Launes C, Garcia-Garcia JJ, Jordan I, Selva L, Rello J, Muñoz-Almagro C. Viral load at diagnosis and influenza A H1N1 (2009) disease severity in children. Influenza Other Resp Viruses 2012; 6: e89-e92.